Volume 14, Issue 6 pp. 1046-1057
STATE OF THE ART ARTICLE

Three-dimensional rotational angiography in congenital heart disease: Present status and evolving future

Sok-Leng Kang MBBS, MRCPCH, MSc

Sok-Leng Kang MBBS, MRCPCH, MSc

Division of Cardiology, The Labatt Family Heart Center, The Hospital for Sick Children, The University of Toronto School of Medicine, Toronto, Canada

Search for more papers by this author
Aimee Armstrong MD, FACC, FSCAI

Aimee Armstrong MD, FACC, FSCAI

The Heart Center, Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus, Ohio

Search for more papers by this author
Gregor Krings MD, PHD

Gregor Krings MD, PHD

Children's Heart Center, Utrecht University, Utrecht, Netherlands

Search for more papers by this author
Lee Benson MD, FRCPC, FACC, FSCAI

Corresponding Author

Lee Benson MD, FRCPC, FACC, FSCAI

Division of Cardiology, The Labatt Family Heart Center, The Hospital for Sick Children, The University of Toronto School of Medicine, Toronto, Canada

Correspondence

Lee Benson, The Hospital for Sick Children, 555 University Ave, Toronto, Ontario, Canada, M5G 1X8.

Email: [email protected]

Search for more papers by this author
First published: 04 September 2019
Citations: 18

Funding information

Sok-Leng Kang has no disclosures.

Aimee Armstrong and Lee Benson have received no funding for this publication and research granted from Siemens Medical Solutions USA, Inc.

Gregor Krings has received no funding for this publication and he is a member of Siemens Healthineers Advisory Board.

Abstract

Three-dimensional rotational angiography (3D-RA) enables volumetric imaging through rotation of the C-arm of an angiographic system and real-time 3D reconstruction during cardiac catheterization procedures. In the field of congenital heart disease (CHD), 3D-RA has gained considerable traction, owing to its capability for enhanced visualization of spatial relationships in complex cardiac morphologies and real time image guidance in an intricate interventional environment. This review provides an overview of the current applications, strengths, and limitations of 3D-RA acquisition in the management of CHD and potential future directions. In addition, issues of dosimetry, radiation exposure, and optimization strategies will be reviewed. Further implementation of 3D-RA will be driven by patient benefits relative to existing 3D imaging capabilities and fusion techniques balanced against radiation exposure.

CONFLICT OF INTEREST

The authors declare that they have no conflicts of interest with the contents of the article.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.